U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021711

Expand all

ABLAVAR (GADOFOSVESET TRISODIUM)
2440MG/10ML (244MG/ML)
Marketing Status: Discontinued
Active Ingredient: GADOFOSVESET TRISODIUM
Proprietary Name: ABLAVAR
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 2440MG/10ML (244MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021711
Product Number: 001
Approval Date: Dec 22, 2008
Applicant Holder Full Name: LANTHEUS MEDICAL IMAGING INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
ABLAVAR (GADOFOSVESET TRISODIUM)
3660MG/15ML (244MG/ML)
Marketing Status: Discontinued
Active Ingredient: GADOFOSVESET TRISODIUM
Proprietary Name: ABLAVAR
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 3660MG/15ML (244MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021711
Product Number: 002
Approval Date: Dec 22, 2008
Applicant Holder Full Name: LANTHEUS MEDICAL IMAGING INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top